Free Trial

Ageas (OTCMKTS:AGESY) Sets New 52-Week High - Here's What Happened

Ageas logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Ageas stock hit a new 52-week high, trading as high as $75.5942 and last at $75.2450 on Tuesday, with about 2,958 shares changing hands.
  • Barclays reissued an overweight rating on Ageas, and the stock's consensus analyst rating is a Moderate Buy (one Buy, one Hold).
  • Technicals indicate an upward trend, with a 50-day moving average of $72.22 and a 200-day moving average of $69.69.
  • MarketBeat previews top five stocks to own in June.

Ageas SA (OTCMKTS:AGESY - Get Free Report)'s stock price reached a new 52-week high on Tuesday . The company traded as high as $75.5942 and last traded at $75.2450, with a volume of 2958 shares trading hands. The stock had previously closed at $75.3570.

Analyst Ratings Changes

Separately, Barclays reissued an "overweight" rating on shares of Ageas in a research note on Tuesday, December 9th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy".

Check Out Our Latest Research Report on AGESY

Ageas Stock Performance

The business has a fifty day moving average of $72.22 and a 200 day moving average of $69.69.

Ageas Company Profile

(Get Free Report)

Ageas is a multinational insurance group headquartered in Brussels, Belgium, offering a broad range of life and non‐life insurance products. Established in 2010 following the restructuring of the Fortis group, Ageas traces its roots back to AG Insurance, founded in 1824. The company operates through two main business segments—protection and savings for individual and corporate clients, and a specialized brokerage and bancassurance network—providing both traditional and innovative risk management solutions.

In the life insurance segment, Ageas offers savings and pension plans, unit‐linked policies, and health insurance coverage, while its non‐life operations include property, casualty, motor, and liability insurance.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ageas Right Now?

Before you consider Ageas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ageas wasn't on the list.

While Ageas currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines